Consistent with our in vitro results, the positive correlation between c-Myc and ORC2 expression, and their association with worse survival outcomes in NSCLC patients, further underscores the clinical relevance of targeting this axis. This evidence concerns the gene ORC2 and non-small cell lung carcinoma.